People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Unicycive Therapeutics, Inc. | — | Biotechnology | Series C | $81.7M | $500.3M | 2023 |
| Hyperion Therapeutics Inc | — | Pharmaceuticals | Series B | $67.9M | $271.7M | 2009 |
| NEXTWAVE PHARMACEUTICALS Inc | — | Pharmaceuticals | Series B | $27.2M | $925.9M | 2011 |
Gaurav Aggarwal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gaurav Aggarwal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 1 | 17 |
| James Healy | 1 | 8 |
| James I. Healy | 1 | 7 |
| ANAND MEHRA | 1 | 7 |
| Sandeep Laumas | 1 | 6 |
| Rob Hopfner | 1 | 6 |
| Bijan Salehizadeh | 1 | 5 |
| Jake Nunn | 1 | 5 |
| Daniel Perez | 1 | 5 |
| Lota S Zoth | 1 | 4 |
| Dayton Misfeldt | 1 | 4 |
| Steve Elms | 1 | 4 |
| Donald Santel | 1 | 4 |
| Jake R. Nunn | 1 | 4 |
| Jay Shepard | 1 | 3 |
| Linda Ara | 1 | 3 |
| Robert Hopfner | 1 | 3 |
| DAVID GRYSKA | 1 | 3 |
| Bo Jesper Hansen | 1 | 2 |
| Michael Burdick | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.